The advance of adjuvant treatment for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by its highly aggressive behavior, early recurrence, and poor outcomes, when compared with other subtypes. Due to the absence of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
China Anti-Cancer Association
2022-02-01
|
| Серія: | Cancer Biology & Medicine |
| Предмети: | |
| Онлайн доступ: | http://www.cancerbiomed.org/index.php/cocr/article/view/1902 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|